![Shannon Morris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shannon Morris
Chief Tech/Sci/R&D Officer at
ERASCA, INC.
Net worth: - $ as of 2026-05-30
Profile
Shannon R.
Morris is President & Partner at Sigma Group, Inc. since 2011.
Dr. Morris is Chief Medical Officer at Erasca, Inc. since 2023.
Former roles include Senior Director at MedImmune LLC from 2014 to 2017, Vice President-Clinical Development at G1 Therapeutics, Inc. from 2017 to 2020, and Vice President & Head-Clinical Development at Istari Oncology, Inc. from 2020 to 2022.
Education includes undergraduate studies at Stanford University and a doctorate from Case Western Reserve University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ERASCA, INC. -.--% | 2026-04-14 | 0 ( -.--% ) | - $ | 2026-05-30 |
Shannon Morris active positions
| Companies | Position | Start |
|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 2022-05-24 |
Sigma Group, Inc.
 Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising services | President | - |
Former positions of Shannon Morris
| Companies | Position | End |
|---|---|---|
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Chief Tech/Sci/R&D Officer | 2022-02-28 |
| G1 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-08-31 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | 2017-02-28 |
Training of Shannon Morris
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigma Group, Inc.
Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising services | Commercial Services |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
- Stock Market
- Insiders
- Shannon Morris
